New York Genome Center

New York Genome Center

Established	2011 (2011)
Research type	Basic (non-clinical), Clinical research and translational research
Field of research	Genomics, Bioinformatics, DNA sequencing, Whole genome sequencing
President	Cheryl A. Moore
Location	New York City, New York, United States
Affiliations	Albert Einstein College of Medicine American Museum of Natural History Cold Spring Harbor Laboratory Columbia University Hospital for Special Surgery IBM Icahn School of Medicine at Mount Sinai The Jackson Laboratory Memorial Sloan Kettering Cancer Center NewYork-Presbyterian Hospital New York Stem Cell Foundation Northwell Health NYU School of Medicine Princeton University The Rockefeller University Roswell Park Cancer Institute Stony Brook Weill Cornell Medicine
Website	New York Genome Center

The New York Genome Center (NYGC) is a 501(c)(3) nonprofit biomedical research organization in New York, New York. A collaboration of academic, medical and industry leaders in New York and other partners throughout the country, the New York Genome Center focuses on translating genomic research into clinical solutions for serious diseases. NYGC faculty hold joint academic appointments at its member institutions and lead clinically focused genomic studies in a number of disease areas, including pediatric and adult cancer, asthma, autism, Alzheimer’s disease, ALS and other serious neurodegenerative diseases. NYGC scientists brings a multidisciplinary and in-depth approach to the field of genomics, conducting research in a wide range of areas, including single cell genomics, gene engineering, population and evolutionary genomics, technology and methods development, statistics, computational biology and bioengineering.

The Center was legally founded in November 2011 as a collaboration among eleven academic institutions to advance genome research, based on leadership from Tom Maniatis and financial support of $2.5 million from each institution as well as a number of private philanthropists, including then Mayor Michael Bloomberg, James Simons and Russell Carson. One year after its founding, NYGC recruited Robert B. Darnell as President and Scientific Director, and formally opened in a newly built facility on September 19–20, 2013.

From November 2012 to December 2016^[update], the Center's President and CEO was Robert B. Darnell. During this period, NYGC had a number of major accomplishments, including the hiring of 17 full time and part time NYGC faculty, award of a $40 million grant to Dr. Darnell as Principal Investigator from the National Human Genome Research Institute to create a Center for Common Disease focused on autism, fundraising that included a $55 million grant from New York State to support genomic medicine, a $100 million matching grant from the Simons Foundation and Carson Family Charitable Trust, a $13.5 million contract from NHLBI, a PCORI grant to centralize clinical data in New York, and collaborations with IBM to explore and develop the use of Watson for Genomics in glioblastoma and more generally in cancer genomics. As of 2016^[update], though the majority of participating institutions remained New York state-based, two institutions were from outside New York: Jackson lab and Princeton University.